05 November 2026
Parkinsonism and Immune Checkpoint Inhibitors, Artificial Intelligence in Administration, SECmeres Discovery
Neurology Today in 5
About
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about parkinsonism as a side effect of immune checkpoint inhibitors, artificial intelligence's use as an administrative tool, and how SECmeres could help with Alzheimer's disease diagnoses.